The hs-CRP Test measures low concentrations of C-reactive protein associated with systemic inflammation and cardiovascular risk
Understanding which concentration you have is critical for accurate dosing
Despite a significant number of bills in 2023 and 2024 that would have required mandated coverage of GLP-1s in Medicaid, state employee health plans, or for health insurers regulated by the state, only Arkansas, California, Maryland, New Mexico, Pennsylvania, and Texas have introduced legislation mandating coverage in 2025 to date
What remains unclear is whether patients taking GLP-1 RAs have an increased risk of aspiration
May your dosing schedule stay consistent, your appetite management stay strong, and your steady state arrive sooner than you expect.